ALUNBRIG® (brigatinib) for ALK+ Metastatic Non-Small Cell Lung …
WEBALUNBRIG is a prescription medicine used to treat adults with non-small cell lung cancer, NSCLC, that has a certain type of abnormal anaplastic lymphoma kinase, ALK, gene and that has spread to other parts of your body. It is not known if ALUNBRIG is safe and effective in children.
ALUNBRIG® (brigatinib) for Healthcare Professionals
WEBALUNBRIG is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
ALUNBRIG® (brigatinib) for Adults With ALK+ Metastatic NSCLC
WEB5 days ago · ALUNBRIG is an FDA-approved oral prescription medication for adults with ALK-positive (ALK+) NSCLC that has spread to other parts of the body (metastatic). ALUNBRIG treatment is one tablet, taken once a day with or without food.
What Is ALK+ NSCLC? - ALUNBRIG® (brigatinib) Patient
WEBWith ALK+ NSCLC, Your Brain Matters Too. Because current treatments are more effective and people with ALK-positive NSCLC live longer without disease progression, up to 75% of patients may eventually experience the disease traveling to their brains.
How to Take ALUNBRIG® (brigatinib)
WEBALUNBRIG Is a Tablet That is Taken Orally Once a Day. Your healthcare provider will start you on a 90 mg dose of ALUNBRIG for the first 7 days of treatment. After the first 7 days of treatment, your healthcare provider may increase your dose to 180 mg orally once daily.
Benefits of ALUNBRIG® (brigatinib)
WEB6 days ago · Learn how ALUNBRIG® may help as your first targeted treatment for ALK+ metastatic non-small cell lung cancer. See Important Safety and Prescribing Information.
Dosing and Administration for ALUNBRIG® (brigatinib)
WEBALUNBRIG® is available in 180-mg, 90-mg, and 30-mg tablets. Review dosing and administration recommendations. See Important Safety Information and Prescribing Information.
Helpful Resources and Patient Stories - ALUNBRIG® (brigatinib) …
WEBSep 23, 2024 · Find patient support materials, patient stories, and treatment resources for ALUNBRIG®. See Important Safety and Prescribing Information.
WEBWhat is ALUNBRIG? ALUNBRIG is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC): • that has a certain type of abnormal anaplastic lymphoma kinase (ALK) gene, and • that has spread to other parts of your body It is not known if ALUNBRIG is safe and effective in children.
WEBALUNBRIG is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved